Oncodna
Charleroi, BE· latest recorded location
ONCODNA is named on 0 US grants and 5 published applications in this corpus. Its most frequent classification is A61K (Medicines and medical preparations).
- Granted patents
- 0
- Published applications
- 5
- Inventors
- 4
- Granted in 2026 so far
- 0
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2024 | 0 | 2 |
| 2025 | 0 | 2 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Technology areas
Share of 5 documents
- A61KMedicines and medical preparations4
- C07KPeptides4
- G16BBioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or4
- C12NMicroorganisms or enzymes2
- C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition1
- C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms1
- G16HHealthcare informatics, i.e. information and communication technology [ict] specially adapted for the1
Recent patents
No granted patents yet.
- Improved vaccine4 Jun 2026US 2026/0151468 A1
- Method to generate a double-stranded dna pool encoding neoantigens of a tumor of a patient28 Aug 2025US 2025/0270736 A1
- RNA Vaccine Comprising an RNA Pool Generated From a Double-Stranded DNA Pool3 Jul 2025US 2025/0215060 A1
- Method to generate personalized neoantigens of a tumor of a patient14 Nov 2024US 2024/0379186 A1
- Method of mutation detection in a liquid biopsy3 Oct 2024US 2024/0327924 A1
Most cited
By later US patents
None of its patents has been cited by a later US patent yet.